CryoValve SG Pulmonary Human Heart Valve, SGPV00, Cryopreserved Decellularized Heart Valve Allogr...

FDA Recall #Z-2531-2024 — Class II — May 28, 2024

Recall #Z-2531-2024 Date: May 28, 2024 Classification: Class II Status: Ongoing

Product Description

CryoValve SG Pulmonary Human Heart Valve, SGPV00, Cryopreserved Decellularized Heart Valve Allograft Prepared with SynerGraft (SG) Technology.

Reason for Recall

Grafts were found to have been approved, released, shipped and implanted with an invalid test results.

Recalling Firm

Artivion, Inc — Kennesaw, GA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

2 valves

Distribution

US Nationwide distribution in the states of CA, DC, FL, and NY.

Code Information

Serial #11673489, exp. 27Jan2026; and serial #12657716, exp. 15Aug2028, UDI-DI: 00877234000447

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated